Sean A. McCarthy - 14 Jun 2021 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
President and CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Issuer symbol
CTMX
Transactions as of
14 Jun 2021
Net transactions value
+$43.47
Form type
4
Filing time
16 Jun 2021, 21:49:21 UTC
Previous filing
08 Jun 2021
Next filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Options Exercise $34.02 +30 +0.38% $1.13 7,839 14 Jun 2021 Direct
transaction CTMX Common Stock Options Exercise $9.45 +10 +0.13% $0.9450 7,849 14 Jun 2021 Direct
holding CTMX Common Stock 193,118 14 Jun 2021 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Options Exercise $0 -30 -0.03% $0.000000 92,113 14 Jun 2021 Common Stock 30 $1.13 Direct F2
transaction CTMX Stock Option (Right to Buy) Options Exercise $0 -10 -0.01% $0.000000 66,742 14 Jun 2021 Common Stock 10 $0.9450 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
F2 100% of the shares subject to the option are fully vested and exercisable.